Beactica Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $294K

  • Investors
  • 11

Beactica Therapeutics General Information

Description

Developer of a medicine discovery platform designed to facilitate the treatment of glioblastoma and other cancers. The company's platform offers protein-based therapeutics that regulate the expression of disease-associated proteins in order to change the chromatin configuration that governs the regulation of DNA transcription and improve the immune system's ability to fight cancer, enabling medical practitioners to treat patients with cancer with improved efficiency and lower risks.

Contact Information

Website
www.beactica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Virdings allé 2
  • 754 50 Uppsala
  • Sweden
+46 018-56
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Virdings allé 2
  • 754 50 Uppsala
  • Sweden
+46 018-56

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beactica Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 18-Jun-2019 $294K Completed Pre-Clinical Trials
7. Later Stage VC 04-Jun-2019 Completed Pre-Clinical Trials
6. Grant 23-Mar-2018 Completed Pre-Clinical Trials
5. Later Stage VC 15-Dec-2014 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Grant 20-Nov-2014 Completed Pre-Clinical Trials
2. Grant 14-Sep-2007 $187K Completed Pre-Clinical Trials
1. Early Stage VC 22-Nov-2006 Completed Startup
To view Beactica Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Beactica Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medicine discovery platform designed to facilitate the treatment of glioblastoma and other cancers. The c
Drug Discovery
Uppsala, Sweden
17 As of 2024

San Francisco, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Beactica Therapeutics Competitors (103)

One of Beactica Therapeutics’s 103 competitors is Atomwise, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Atomwise Venture Capital-Backed San Francisco, CA
Mitobridge Formerly VC-backed Cambridge, MA
Cellestia Venture Capital-Backed Basel, Switzerland
Theolytics Venture Capital-Backed Oxford, United Kingdom
Centrose Venture Capital-Backed Middleton, WI
You’re viewing 5 of 103 competitors. Get the full list »

Beactica Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beactica Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
SWElife Government
Flerie Venture Capital Minority
M2Capital PE/Buyout Minority
Paab Venture Capital Minority
Horizon 2020 Government
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Beactica Therapeutics FAQs

  • When was Beactica Therapeutics founded?

    Beactica Therapeutics was founded in 2006.

  • Where is Beactica Therapeutics headquartered?

    Beactica Therapeutics is headquartered in Uppsala, Sweden.

  • What is the size of Beactica Therapeutics?

    Beactica Therapeutics has 17 total employees.

  • What industry is Beactica Therapeutics in?

    Beactica Therapeutics’s primary industry is Drug Discovery.

  • Is Beactica Therapeutics a private or public company?

    Beactica Therapeutics is a Private company.

  • What is Beactica Therapeutics’s current revenue?

    The current revenue for Beactica Therapeutics is .

  • Who are Beactica Therapeutics’s investors?

    SWElife, Flerie, M2Capital, Paab, and Horizon 2020 are 5 of 11 investors who have invested in Beactica Therapeutics.

  • Who are Beactica Therapeutics’s competitors?

    Atomwise, Mitobridge, Cellestia, Theolytics, and Centrose are some of the 103 competitors of Beactica Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »